Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy
This article aims to describe estimated prevalence of integrase strand transfer inhibitor resistance within a single clinic network in Chicago, IL, USA, and identify risk factors for resistance and virological failure.